Induced After Nivolumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ EpiVax Therapeutics, Inc. ("EVT"), an emerging biotechnology company, today announced that an abstract highlighting its Ancer® platform will be.

United statesNicole ruggieroEpivax epimatrixBill martinMichael princiottaSociety for immunotherapy of cancerEpivax therapeutics incEpivax incPrnewswire epivax therapeutics incVax therapeuticsAnnual meetingStealthier mutanomesInduced after nivolumabEpivax therapeuticsAnnie de grootVax therapeutic ancer